Cardiology

SGLT2 inhibitors may cut risk for heart failure hospitalization

(HealthDay)—For patients with type 2 diabetes (T2D), with or without cardiovascular disease (CVD), use of sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with glucagon-like peptide-1 receptor agonists (GLP-1 ...

Cardiology

Flu jab after heart attack should become standard care

Influenza vaccination reduces the risk of all-cause death, myocardial infarction, or stent thrombosis at 12 months in hospitalized patients with myocardial infarction or high-risk coronary disease, according to late breaking ...

Cardiology

Gum disease linked with new onset heart disease

Gum disease is associated with an increased risk of cardiovascular disease: the more severe the periodontitis, the higher the risk. The findings are presented at ESC Congress 2021. The association was particularly evident ...

Medical research

Implementation of primary PCI in the management of STEMI in Egypt

In a new publication from Cardiovascular Innovations and Applications, Sameh Shaheen, Ayman Helal, and Islam Anan from Ain Shams University, Cairo, Egypt, Fayoum University, Fayoum, Egypt, and Queen Alexandra Hospital, Portsmouth, ...

page 25 from 40